Federal Register / Vol. 62, No. 53 / Wednesday, March 19, 1997 / Rules and Regulations 12949

limited to, the legal and financial structure of

the transaction, the collateral, all other types

of credit enhancement, and the term of the

transaction.

(c) A corporate credit union which has met

the requirements of paragraph (a) of this Part

II may:

(1) Except for investments in a wholesale

corporate credit union, invest in nonsecured

obligations of any single domestic issuer up

to 250 percent of the sum of reserves and

undivided earnings and paid-in capital;

(2) Purchase long-term investments rated

no lower than A¥ (or equivalent);

(3) Purchase asset-backed securities rated

no lower than AA (or equivalent);

(4) Engage in short sales of permissible

investments to reduce interest rate risk;

(5) Purchase principal only (PO) stripped

mortgage-backed securities to reduce interest

rate risk;

(6) Purchase CMOs/REMICs using fewer

prepayment models than required in

§ 704.5(c)(6);

(7) Enter into a dollar roll transaction; and

(8) Engage in when-issued trading, when

accounted for on a trade date basis.

(d) In performing the rate stress tests set

forth in § 704.8(d)(1)(i), the NEV of a

corporate credit union which has met the

requirements of paragraph (a) of this Part II

may decline as much as 50 percent.

(e) The maximum aggregate amount in

secured and unsecured loans and irrevocable

lines of credit to any one member credit

union, excluding pass-through and

guaranteed loans from the CLF and the

NCUSIF, shall be established by the board of

directors as a percentage of the corporate

credit union’s capital plus pledged shares.

Part III

(a) A corporate credit union which has met

the requirements of paragraph (a) of either

Part I or Part II of this Appendix may invest

in:

(1) Debt obligations of a foreign country;

and

(2) Deposits in, the sale of federal funds to,

and debt obligations of foreign banks or

obligations guaranteed by these banks.

(b) All foreign investments are subject to

the following requirements:

(i) Short-term investments must be rated no

lower than A–1 (or equivalent);

(ii) Long-term investments must be rated

no lower than AA (or equivalent);

(iii) A sovereign issuer, and/or the country

in which a bank issuer/guarantor is

organized, must be rated no lower than AA

(or equivalent) for political and economic

stability;

(iv) A bank issuer/guarantor must be rated

no lower than AA;

(v) For each approved foreign bank line,

the corporate credit union must identify the

specific banking centers and branches to

which it will lend funds;

(vi) Non secured obligations of any single

foreign issuer may not exceed 150 percent of

the sum of reserves and undivided earnings

and paid-in capital; and

(vii) Non secured obligations in any single

foreign country may not exceed 500 percent

of the sum of reserves and undivided

earnings and paid-in capital.

Part IV

A corporate credit union which has met

the requirements of paragraph (a) of either

Part I or Part II of this Appendix may engage

in derivatives transactions which are directly

related to its financial activities and which

have been specifically approved by NCUA. A

corporate credit union may use such

derivatives authority only for the purposes of

creating structured instruments and hedging

its own balance sheet and the balance sheets

of its members.

PART 709—INVOLUNTARY

LIQUIDATION OF FEDERAL CREDIT

UNIONS AND ADJUDICATION OF

CREDITOR CLAIMS INVOLVING

FEDERALLY INSURED CREDIT

UNIONS IN LIQUIDATION

2. The authority citation for part 709

continues to read as follows:

Authority: 12 U.S.C. 1766; Pub. L. 101–73,

103 Stat. 183, 530 (1989) (12 U.S.C. 1787 et

seq.).

3. Section 709.5 is amended by

revising paragraphs (b)(7) and (b)(8) and

adding paragraph (b)(9) to read as

follows:

§ 709.5 Payout priorities in involuntary

liquidation.

* * * * *

(b) * * *

(7) In a case involving liquidation of

a corporate credit union, membership

capital;

(8) In a case involving liquidation of

a low-income designated credit union,

any outstanding secondary capital

accounts issued pursuant to the

authority of §§ 701.34 or 741.204(c) of

this chapter; and

(9) In a case involving liquidation of

a corporate credit union, paid-in capital.

* * * * *

PART 741—REQUIREMENTS FOR

INSURANCE

4. The authority citation for part 741

continues to read as follows:

Authority: 12 U.S.C. 1757, 1766, and 1781–

1790. Section 741.4 is also authorized by 31

U.S.C. 3717.

5. Section 741.219 is added to read as

follows:

§ 741.219 Investment requirements.

Any credit union which is insured

pursuant to Title II of the Act must

adhere to the requirements stated in part

703 of this chapter concerning

transacting business with corporate

credit unions.

[FR Doc. 97–6417 Filed 3–18–97; 8:45 am]

BILLING CODE 7535–01–P

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. 94–CE–34–AD; Amendment 39–

9967; AD 97–06–10]

RIN 2120–AA64

Airworthiness Directives; Raytheon

Aircraft Company (Formerly Beech

Aircraft Corporation) Model 76

Airplanes

AGENCY: Federal Aviation

Administration, DOT.

ACTION: Final rule.

SUMMARY: This amendment supersedes

Airworthiness Directive (AD) 91–14–14,

which currently requires repetitively

inspecting the main landing gear (MLG)

‘‘A’’ frame assemblies for cracks on

Raytheon Aircraft Company (Raytheon)

Model 76 airplanes (formerly referred to

as Beech Model 76 airplanes), and

replacing any assembly found cracked.

AD 91–14–14 resulted from reports of

fatigue cracks developing on the MLG

‘‘A’’ frame assemblies of the affected

airplanes. Raytheon has developed

improved design MLG ‘‘A’’ frame

assemblies, and the Federal Aviation

Administration (FAA) has determined

that Model 76 airplanes with an

improved design ‘‘A’’ frame assembly

installed on both the left and right MLG

should be exempt from AD 91–14–14.

This action retains the requirement of

repetitively inspecting the MLG ‘‘A’’

frame assemblies for cracks and

replacing any cracked ‘‘A’’ frame

assembly only for those Model 76

airplanes that do not have the improved

design parts installed. The actions

specified by this AD are intended to

prevent MLG failure because of a

cracked ‘‘A’’ frame assembly, which

could result in loss of control of the

airplane during landing operations.

DATES: Effective May 16, 1997.

The incorporation by reference of

certain publications listed in the

regulations is approved by the Director

of the Federal Register as of May 16,

1997.

ADDRESSES: Service information that

applies to this AD may be obtained from

the Raytheon Aircraft Company, P.O.

Box 85, Wichita, Kansas 67201–0085.

This information may also be examined

at the FAA, Central Region, Office of the

Assistant Chief Counsel, Attention:

Rules Docket No. 94–CE–34–AD, Room

1558, 601 E. 12th Street, Kansas City,

Missouri 64106; or at the Office of the

Federal Register, 800 North Capitol

Street, NW., suite 700, Washington, DC.
12950 Federal Register / Vol. 62, No. 53 / Wednesday, March 19, 1997 / Rules and Regulations

FOR FURTHER INFORMATION CONTACT: Mr.

Larry Engler, Aerospace Safety

Engineer, FAA, Wichita Aircraft

Certification Office, 1801 Airport Road,

Mid-Continent Airport, Wichita, Kansas

67209; telephone (316) 946-4122;

facsimile (316) 946–4407.

SUPPLEMENTARY INFORMATION:

Events Leading to the Issuance of the

This AD

A proposal to amend part 39 of the

Federal Aviation Regulations (14 CFR

part 39) to include an AD that would

apply to Raytheon Model 76 airplanes

(formerly referred to as Beech Model 76

airplanes) was published in the Federal

Register as a notice of proposed

rulemaking (NPRM) on October 18, 1996

(61 FR 54368). The NPRM proposed to

supersede AD 91–14–14 with a new AD

that would retain the requirement of

repetitively inspecting the MLG ‘‘A’’

frame assemblies for cracks and

replacing any part found cracked, but

would exempt those airplanes with both

a P/N 105–810023-75 (left) and P/N

105–810023–76 (right) MLG ‘‘A’’ frame

assembly installed. Accomplishment of

the proposed repetitive inspections as

specified in the NPRM would be in

accordance with Raytheon Mandatory

Service Bulletin No. 2361, Revision III,

dated June 1996.

The NPRM was the result of Raytheon

developing improved design MLG ‘‘A’’

frame assemblies, and the FAA

determining that Model 76 airplanes

with an improved design ‘‘A’’ frame

assembly installed on both the left and

right MLG should be exempt from AD

91–14–14.

Interested persons have been afforded

an opportunity to participate in the

making of this amendment. No

comments were received on the

proposed rule or the FAA’s

determination of the cost to the public.

The FAA’s Determination

After careful review of all available

information related to the subject

presented above, the FAA has

determined that air safety and the

public interest require the adoption of

the rule as proposed except for minor

editorial corrections. The FAA has

determined that these minor corrections

will not change the meaning of the AD

and will not add any additional burden

upon the public than was already

proposed.

Cost Impact

The FAA estimates that 437 airplanes

in the U.S. registry will be affected by

this AD, that it will take approximately

2 workhours per airplane to accomplish

the required action, and that the average

labor rate is approximately $60 an hour.

Based on these figures, the total cost

impact of the AD on U.S. operators is

estimated to be $52,440. These figures

only take into account the cost of the

required initial inspection; repetitive

inspection costs and costs for replacing

any cracked MLG ‘‘A’’ frame assemblies

are not included in these figures.

The FAA has no way of determining

how many airplanes will have cracked

MLG ‘‘A’’ frame assemblies or how

many repetitive inspections each

affected owner/operator will incur over

the life of the airplane.

The only difference between this AD

and AD 91–14–14 is that this AD

exempts airplanes with the improved

MLG ‘‘A’’ frame assemblies installed.

Therefore, the cost impact of this AD is

less than that already required by AD

91–14–14 because the FAA believes that

some airplanes will have the improved

MLG ‘‘A’’ frame assemblies installed.

Regulatory Impact

The regulations adopted herein will

not have substantial direct effects on the

States, on the relationship between the

national government and the States, or

on the distribution of power and

responsibilities among the various

levels of government. Therefore, in

accordance with Executive Order 12612,

it is determined that this final rule does

not have sufficient federalism

implications to warrant the preparation

of a Federalism Assessment.

For the reasons discussed above, I

certify that this action (1) is not a

‘‘significant regulatory action’’ under

Executive Order 12866; (2) is not a

‘‘significant rule’’ under DOT

Regulatory Policies and Procedures (44

FR 11034, February 26, 1979); and (3)

will not have a significant economic

impact, positive or negative, on a

substantial number of small entities

under the criteria of the Regulatory

Flexibility Act. A copy of the final

evaluation prepared for this action is

contained in the Rules Docket. A copy

of it may be obtained by contacting the

Rules Docket at the location provided

under the caption ADDRESSES.

List of Subjects in 14 CFR Part 39

Air transportation, Aircraft, Aviation

safety, Incorporation by reference,

Safety.

Adoption of the Amendment

Accordingly, pursuant to the

authority delegated to me by the

Administrator, the Federal Aviation

Administration amends part 39 of the

Federal Aviation Regulations (14 CFR

part 39) as follows:

PART 39—AIRWORTHINESS

DIRECTIVES

1. The authority citation for part 39

continues to read as follows:

Authority: 49 USC 106(g), 40113, 44701.

§ 39.13 [Amended]

2. Section 39.13 is amended by

removing Airworthiness Directive (AD)

91–14–14, Amendment 39–7055 (56 FR

29173, June 26, 1991), and by adding a

new AD to read as follows:

97–06–10 Raytheon Aircraft Company

(formerly Beech Aircraft Corporation):

Amendment 39–9967; Docket No. 94–

CE–34–AD. Supersedes AD 91–14–14,

Amendment 39–7055.

Applicability: Model 76 airplanes (serial

numbers ME–1 through ME–437), certificated

in any category, that do not have both a part

number (P/N) 105–810023–75 (left) and P/N

105–810023–76 (right) main landing gear

(MLG) ‘‘A’’ frame assembly installed.

Note 1: This AD applies to each airplane

identified in the preceding applicability

provision, regardless of whether it has been

modified, altered, or repaired in the area

subject to the requirements of this AD. For

airplanes that have been modified, altered, or

repaired so that the performance of the

requirements of this AD is affected, the

owner/operator must request approval for an

alternative method of compliance in

accordance with paragraph (e) of this AD.

The request should include an assessment of

the effect of the modification, alteration, or

repair on the unsafe condition addressed by

this AD; and, if the unsafe condition has not

been eliminated, the request should include

specific proposed actions to address it.

Compliance: Required initally within the

next 50 hours time-in-service (TIS) after the

effective date of this AD, unless already

accomplished (compliance with AD 91–14–

14), and thereafter at intervals not to exceed

100 hours TIS .

To prevent MLG failure because of a

cracked ‘‘A’’ frame assembly, which could

result in loss of control of the airplane during

landing operations, accomplish the

following:

(a) Inspect, using both visual and dye

penetrant methods, both the left and right

MLG ‘‘A’’ frame assemblies for cracks in

accordance with the ACCOMPLISHMENT

INSTRUCTIONS section of Raytheon

Mandatory Service Bulletin No. 2361,

Revision III, dated June 1996. Pay particular

attention to the tips of the gussets and the

small corrosion treatment hole adjacent to

the gusset.

(b) If any MLG ‘‘A’’ frame assembly is

found cracked during any inspection

required by this AD, prior to further flight,

replace the assembly with one of the

following in accordance with Chapter 32 of

the Raytheon Model 76 Maintenance Manual:

(1) A new MLG ‘‘A’’ frame assembly with

the same P/N as that found cracked. The 100-

hour TIS repetitive inspection requirement

still applies when this design ‘‘A’’ frame is

installed.

(2) A P/N 105–810023–75 (left) or P/N

105–810023–76 (right) main MLG ‘‘A’’ frame
Federal Register / Vol. 62, No. 53 / Wednesday, March 19, 1997 / Rules and Regulations 12951

assembly, as applicable. Repetitive

inspections are no longer required on an

MLG ‘‘A’’ frame assembly incorporating this

design configuration. Repetitive inspections

are still required on an MLG ‘‘A’’ frame

assembly if it does not incorporate this

improved design configuration.

(c) Installing both P/N 105–810023–75

(left) and P/N 105–810023–76 (right) MLG

‘‘A’’ frame assemblies eliminates the

repetitive inspection requirement of this AD.

(d) Special flight permits may be issued in

accordance with sections 21.197 and 21.199

of the Federal Aviation Regulations (14 CFR

21.197 and 21.199) to operate the airplane to

a location where the requirements of this AD

can be accomplished.

(e) An alternative method of compliance or

adjustment of the compliance time that

provides an equivalent level of safety may be

approved by the Manager, Wichita Aircraft

Certification Office (ACO), 1801 Airport

Road, Room 100, Mid-Continent Airport,

Wichita, Kansas 67209. The request shall be

forwarded through an appropriate FAA

Maintenance Inspector, who may add

comments and then send it to the Manager,

Wichita ACO.

Note 2: Information concerning the

existence of approved alternative methods of

compliance with this AD, if any, may be

obtained from the Wichita ACO.

(f) The inspection required by this AD shall

be done in accordance with Raytheon

Mandatory Service Bulletin No. 2361,

Revision III, dated June 1996. This

incorporation by reference was approved by

the Director of the Federal Register in

accordance with 5 U.S.C. 552(a) and 1 CFR

part 51. Copies may be obtained from the

Raytheon Aircraft Company, P.O. Box 85,

Wichita, Kansas 67201–0085. Copies may be

inspected at the FAA, Central Region, Office

of the Assistant Chief Counsel, Room 1558,

601 E. 12th Street, Kansas City, Missouri, or

at the Office of the Federal Register, 800

North Capitol Street, NW., suite 700,

Washington, DC.

(g) This amendment (39–9967) supersedes

AD 91–14–14, Amendment 39–7055.

(h) This amendment (39–9967) becomes

effective on May 16, 1997. Issued in Kansas

City, Missouri, on March 6, 1997.

Michael Gallagher,

Manager, Small Airplane Directorate, Aircraft

Certification Service.

[FR Doc. 97–6539 Filed 3–18–97; 8:45 am]

BILLING CODE 4910–13–U

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

21 CFR Part 73

[Docket No. 91C–0189]

Listing of Color Additives for Coloring

Contact Lenses; 1,4-Bis[(2-

hydroxyethyl)amino]-9,10-

anthracenedione bis(2-propenoic)ester

copolymers; Confirmation of Effective

Date

AGENCY: Food and Drug Administration,

HHS.

ACTION: Final rule; confirmation of

effective date.

SUMMARY: The Food and Drug

Administration (FDA) is confirming the

effective date of November 5, 1996, for

the final rule that amended the color

additive regulations to provide for the

safe use of the colored reaction products

formed by copolymerizing 1,4-bis[(2-

hydroxyethyl)amino]-9,10-

anthracenedione bis(2-propenoic)ester

either with glyceryl methacrylate/

methyl methacrylate/ethylene glycol

dimethacrylate monomers or with N,Ndimethyl acrylamide/methyl

methacrylate/ethylene glycol

dimethacrylate monomers to form

contact lenses.

DATES: Effective date confirmed:

November 5, 1996.

FOR FURTHER INFORMATION CONTACT:

Helen R. Thorsheim, Center for Food

Safety and Applied Nutrition (HFS–

216), Food and Drug Administration,

200 C St. SW., Washington, DC 20204,

202–418–3092.

SUPPLEMENTARY INFORMATION: In the

Federal Register of October 3, 1996 (61

FR 51584), FDA amended 21 CFR part

73 to provide for the safe use of the

colored reaction products formed by

copolymerizing 1,4-bis[(2-

hydroxyethyl)amino]-9,10-

anthracenedione bis(2-propenoic)ester

either with glyceryl methacrylate/

methyl methacrylate/ethylene glycol

dimethacrylate monomers or with N,Ndimethyl acrylamide/methyl

methacrylate/ethylene glycol

dimethacrylate monomers to form

contact lenses.

FDA gave interested persons until

November 4, 1996, to file objections or

requests for a hearing. The agency

received no objections or requests for a

hearing on the final rule. Therefore,

FDA finds that the final rule published

in the Federal Register of October 3,

1996, should be confirmed.

List of Subjects in 21 CFR Part 73

Color additives, Cosmetics, Drugs,

Medical devices.

Therefore, under the Federal Food,

Drug, and Cosmetic Act (secs. 201, 401,

402, 403, 409, 501, 502, 505, 601, 602,

701, 721 (21 U.S.C. 321, 341, 342, 343,

348, 351, 352, 355, 361, 362, 371, 379e))

and under authority delegated to the

Commissioner of Food and Drugs (21

CFR 5.10), notice is given that no

objections or requests for a hearing were

filed in response to the October 3, 1996,

final rule. Accordingly, the amendments

promulgated thereby became effective

November 5, 1996.

Dated: March 5, 1997.

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

[FR Doc. 97–6849 Filed 3–18–97; 8:45 am]

BILLING CODE 4160–01–F

21 CFR Part 558

New Animal Drugs for Use in Animal

Feeds; Bacitracin Methylene

Disalicylate and Chlortetracycline

AGENCY: Food and Drug Administration,

HHS.

ACTION: Final rule.

SUMMARY: The Food and Drug

Administration (FDA) is amending the

animal drug regulations to reflect

approval of a new animal drug

application (NADA) filed by Alpharma

Inc. The NADA provides for using

currently approved, single ingredient,

Type A medicated articles in making

combination drug, Types B and C

medicated, swine feeds containing

bacitracin methylene disalicylate and

chlortetracycline. The Type C

medicated feed is used for increased

rate of weight gain and improved feed

efficiency due to the activity of

bacitracin, and treatment of enteritis

and pneumonia caused by certain

bacteria susceptible to chlortetracycline.

EFFECTIVE DATE: March 19, 1997.

FOR FURTHER INFORMATION CONTACT:

George K. Haibel, Center for Veterinary

Medicine (HFV–133), Food and Drug

Administration, 7500 Standish Pl.,

Rockville, MD 20855, 301–594–1644.

SUPPLEMENTARY INFORMATION: Alpharma

Inc., One Executive Dr., Fort Lee, NJ

07024, filed NADA 141–059, which

provides for combining separately

approved, Type A medicated articles

containing BMD (bacitracin methylene

disalicylate (bacitracin MD)) and CTC

(chlortetracycline) in making

combination drug, Type C medicated

swine feed. The Type C medicated feed